ECRI, the most trusted voice in healthcare, announces the release of an enhanced value analysis workflow solution that drives team transparency, clinical engagement, and improves efficiency of the medical product decision-making process.
ECRI’s Value Analysis Workflow empowers supply chain leaders, value analysis teams, and clinicians to reach consensus on complex technology purchasing decisions based on sound clinical evidence.
ECRI improves value analysis decisions and helps reduce healthcare costs during the COVID-19 pandemic with its release of a newly enhanced Value Analysis Workflow solution.
The automated decision management tool integrates cost analysis, product comparisons, and clinical evidence, unlocking savings potential and reducing turnaround time.
Value Analysis Workflow increases physician engagement and builds consensus with unbiased clinical evidence from ECRI, the most trusted voice in healthcare.
“The COVID-19 pandemic is tightening financial pressures on an already strained healthcare system,” says Marcus Schabacker, MD, PhD, president and CEO, ECRI.
“Our new value analysis workflow adds much-needed transparency, safety, and clinical evidence assurance that leaders can rely on to stretch scarce resources when selecting new patient-care technologies.”
ECRI’s Value Analysis Workflow integrates pricing and utilization analytics, evidence-based assessments, and comparative product evaluations to reduce clinical spend […]
read more here —> www.prnewswire.com